Related Experiment Videos
Asthma controller medications: what do patients want?
T A Balsbaugh1, C V Chambers, J J Diamond
1Department of Family Medicine, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA. thomas.balsbaugh@mail.tju.edu
Summary
Patients with asthma prioritize avoiding blood tests for controller medications above all else. Medication dosing frequency is also a key factor, while administration route is less important.
Area of Science:
- Pulmonary Medicine
- Patient-Reported Outcomes
- Pharmacoeconomics
Background:
- Asthma controller medications are crucial for long-term disease management.
- Patient adherence to prescribed asthma treatment plans is often suboptimal.
- Understanding patient preferences is key to improving medication selection and adherence.
Purpose of the Study:
- To identify and quantify patient preferences for key attributes of asthma controller medications.
- To determine the relative importance of route of administration, dosing frequency, and need for blood monitoring.
Main Methods:
- Cross-sectional survey of 394 primary care patients diagnosed with asthma.
- Conjoint analysis (trade-off analysis) to assess preferences for hypothetical medications.
- Quantification of patient willingness to accept or reject medication features.
Main Results:
- Blood test monitoring was the most significant deterrent, accounting for 45% of preference variation.
- Dosing frequency strongly influenced patient decisions, explaining 40% of variation.
- Route of administration had a lesser impact, accounting for only 15% of variation.
Conclusions:
- Asthma patients strongly prefer controller medications that do not require blood test monitoring.
- Medication dosing frequency is a critical factor influencing patient choice.
- Incorporating patient preferences into treatment decisions may enhance adherence and physician-patient collaboration.